What is the current status of cell therapies today? It's an exciting time to be in cell therapy manufacturing and commercialization, particularly in the oncology space. This year alone, we've seen the ...

Adoptive therapies based on CAR/TCR T cells—that is, T cells with an engineered chimeric antigen receptor (CAR) or a T-cell receptor (TCR)—have shown promise for a range of cancers, offering hope to ...

PHC Corporation’s Biomedical Division (Head Office: Chiyoda-ku, Tokyo; President: Nobuaki Nakamura; hereinafter “PHCbi”), a global provider of laboratory sample storage and cell cultivation solutions ...

Not all patients respond well to chimeric antigen receptor (CAR) T cell therapies, which reprogram a patient’s own immune cells to recognize and attack cancer. A way to optimize these treatments is to ...

Europe’s battery startups keep hitting the same wall: expensive power, slower scaling, heavy capex, and relentless price competition from Asian giants backed by industrial policy. Without competitive ...

Solid-state batteries promise greater safety, higher energy density, and new degrees of freedom in cell design. Yet the path from laboratory cell to industrial production is challenging. Laser ...

CAPEX investment for setting up the PERC production is higher in the case of a MLD setup. Image: Fraunhofer ISE A solar cell manufacturing plant can reduce water consumption by up to 79% with existing ...

Solar cell photovoltaic research, development, and manufacturing continue to rapidly move forward with new advances in solar texture and metallization manufacturing leading to higher efficiency solar ...

Anza, a subscription-based data and analytics software platform, released its Q2 2025 Domestic Content Insights report that reveals trends in domestic manufacturing of solar modules and battery energy ...

Wang tells PV Tech Premium that copper offers a ‘a compelling combination’ of traits to replace silver. Image: AIKO. This Premium article, which was one of the most read Premium articles in 2025, has ...